Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-04-21

Clinical Trial Update: Quantitative Renal Uptake Using TC99m DMSA in Hypertensive &/or Diabetic Patients. [Phase 4]

View source ↗

Summary

Phase 4 trial updating the quantitative assessment of renal uptake using technetium-99m DMSA in patients with diabetes mellitus and hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Technetium-99m DMSA (technetium-99m labeled dimercaptosuccinic acid (DMSA))

Snippet

Sponsor: Assiut University | Conditions: Diabetes Mellitus, Hypertension | Phase 4 | Status: UNKNOWN